gms | German Medical Science

23rd Annual Meeting of the German Retina Society

German Retina Society

24.09. - 25.09.2010, Freiburg

II. Age Related Macular Degeneration – Therapy

Meeting Abstract (10rg09)

Serous Retinal Pigment Epithelium Detachment within Exudative Age-related Macular Degeneration – Anti-VEGF Therapy

Lommatzsch A, Heimes B, Spital G, Dietzel M, Gutfleisch M, Pauleikhoff D
[Full Text]
Meeting Abstract (10rg10)

Treatment of serous pigment-epithelium-layer-elevation (PED) by intravitreal injections of Ranibizumab and Bevacizumab

Altmann M, Radeck V, Helbig H, Gamulescu A
[Full Text]
Meeting Abstract (10rg11)

Pigment epithelium tears following intravitreal anti-VEGF-therapy for vascularised pigment epithelium detachment (PED) in AMD: development of morphology and visual acuity

Gutfleisch M, Heimes B, Schuhmacher M, Spital G, Lommatzsch A, Pauleikhoff D
[Full Text]
Meeting Abstract (10rg12)

Treatment of wet-age related macular degeneration (AMD) with rt-PA and anti-VEGF

Schmidt JC, Thimm CBG
[Full Text]
Kongressabstract (10rg13)

Intravitreale Injektion von Bevacizumab, recombinant tissue plasminogen activator (rTPA) und Gas bei der Behandlung von submakulärer Blutung bei der AMD

Guthoff R, Meigen T, Guthoff T, Göbel W
[Full Text]
Meeting Abstract (10rg14)

Individual Recurrence Intervals After Ranibizumab Therapy For neovascular Age-related Macular Degeneration

Hörster R, Ristau T, Kirchhof B, Liakopoulos S
[Full Text]
Meeting Abstract (10rg15)

Statistical analyses, modelling of response characteristics, saturation of therapy and optimum of AMD treatment with less than 12 injections of Rainibizumab/year

Gerding H, Timmermann M, Hefner L
[Full Text]
Meeting Abstract (10rg16)

Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in loss of visual acuity

Müther PS, Hermann MM, Koch K, Kirchhof B, Fauser S
[Full Text]